Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;55(5):1231-7.
doi: 10.3349/ymj.2014.55.5.1231.

The added value of double dose gadolinium enhanced 3D T2 fluid-attenuated inversion recovery for evaluating small brain metastases

Affiliations

The added value of double dose gadolinium enhanced 3D T2 fluid-attenuated inversion recovery for evaluating small brain metastases

Sung Jun Ahn et al. Yonsei Med J. 2014 Sep.

Abstract

Purpose: Single dose gadolinium (Gd) enhanced fluid-attenuated inversion recovery (FLAIR) is helpful for visualizing superficial parenchymal metastases. However, the usefulness of FLAIR with a higher dose of Gd is uncertain. The aim of our study was two-folds: first, to prove that the signal to noise ratio (SNR) of small brain metastases is higher than large brain metastases on double-dose (DD) enhanced FLAIR and, second, to explore the added value of DD Gd enhanced FLAIR in relation to T1 GRE for evaluating small brain metastases.

Materials and methods: For the first purpose, 50 pairs of small (2 mm<diameter≤5 mm) and large brain metastases (diameter>5 mm) were included. The difference in the SNR and contrast ratio (CR) between small and large metastases on DD Gd-enhanced 3D T2 FLAIR was compared by Wilcoxon signed-rank tests. For the second purpose, a total of 404 small metastases were included. The diagnostic sensitivities between 3D T1 gradient echo (GRE) alone and combined results of 3D T1 GRE and 3D T2 FLAIR were compared with McNemar test.

Results: The SNR and CR of small brain metastases were significantly higher than those of large brain metastases (p<0.001). In qualitative analysis, the diagnostic sensitivities for small brain metastases were significantly higher for 3D T1 GRE plus 3D T2 FLAIR than 3D T1 GRE alone regardless of scan time (p<0.001).

Conclusion: Small brain metastases showed higher signal intensity than large brain metastases on the DD Gd enhanced 3D T2 FLAIR images. DD Gd enhanced 3D T2 FLAIR imaging may have a complementary role to 3D T1 GRE for evaluating small brain metastases.

Keywords: CNS; MR-imaging; metastases.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Fig. 1
Fig. 1
Comparison of SNR and CR between small metastasis (2 mm5 mm) on DD Gd enhanced 3D T2 FLAIR. (A) SNRs of small and large brain metastases (32.82±13.03 vs. 19.38±11.73). (B) CRs of small and large brain metastases (2.14±0.57 vs. 1.29±0.63). SNR, signal-to-noise ratio; DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; CR, contrast ratio.
Fig. 2
Fig. 2
A 45-year-old patient with renal cell cancer. (A) A larger brain metastasis (8 mm) with dark signal intensity and peri-lesional edema in the left frontal lobe on DD Gd-enhanced 3D T2 FLAIR (SNR: 9.61). (B) The same lesion with strong enhancement on post DD gadolinium enhanced 3D T1 GRE. (C) Another small brain metastasis (4.2 mm) in the left frontal lobe with high signal intensity on DD Gd-enhanced 3D T2 FLAIR (SNR: 21.63). (D) The same lesion with enhancement on DD Gd-enhanced 3D T1 GRE. SNR, signal-to-noise ratio; DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; GRE, gradient echo.
Fig. 3
Fig. 3
68-year-old female patient with lung cancer. (A) In first review, both reviewers missed the left frontal small brain metastases on early phase DD Gd enhanced 3D T1 GRE, because they regarded them as enhancement of the cortical vein. (B) On late phase DD Gd enhanced 3D T2 FLAIR, the same lesion with high signal intensity was more prominent and distinct from the surrounding normal parenchyma. Both reviewers retrospectively detected the left frontal lesion on 3D T1 GRE after reviewing the 3D T2 FLAIR. DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; GRE, gradient echo.
Fig. 4
Fig. 4
A 49-year-old male patient with renal cell cancer. (A) On early DD Gd-enhanced 3D T1 GRE, brain metastasis is not detected. (B) On late phase DD Gd enhanced 3D T2 FLAIR, small enhancing metastasis is clearly demonstrated in the right frontal lobe (arrow). (C) Two month follow up 3D T1 GRE reveals the small brain metastases in the right frontal lobe (dashed arrow). DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; GRE, gradient echo.

References

    1. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol. 1993;33:583–590. - PubMed
    1. Patchell RA. The management of brain metastases. Cancer Treat Rev. 2003;29:533–540. - PubMed
    1. Chang SD, Lee E, Sakamoto GT, Brown NP, Adler JR., Jr Stereotactic radiosurgery in patients with multiple brain metastases. Neurosurg Focus. 2000;9:e3. - PubMed
    1. Yuh WT, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol. 1995;16:373–380. - PMC - PubMed
    1. Sze G, Johnson C, Kawamura Y, Goldberg SN, Lange R, Friedland RJ, et al. Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol. 1998;19:821–828. - PMC - PubMed